Great Sustainability Results From Appropriate Antihypertensive Therapy

Related Experiment Video

Updated: Jul 27, 2025

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
04:37

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension

Published on: June 6, 2025

180

Francesco Ferrara1, Andrea Zovi2, Eduardo Nava3

  • 1Pharmaceutical Department, Hospital Pharmacist Manager, ASL Napoli 3 Sud, Naples, Italy.

Current Problems in Cardiology
|June 10, 2023
PubMed

Insights

This study analyzes prescribing trends for antihypertensive drugs in Italy, highlighting variations in cost and efficacy among drug classes like ACE inhibitors and diuretics. Understanding these differences is key for effective cardiovascular disease management.

Area of Science:

  • Cardiology
  • Pharmacoeconomics
  • Pharmacology

Background:

  • Cardiovascular diseases are a leading cause of mortality and hospitalization globally.
  • Numerous antihypertensive drug classes, including ACE inhibitors, sartans, calcium antagonists, beta blockers, and diuretics, are widely used.
  • Significant variations exist in the efficacy, tolerability, and cost of these medications.

Purpose of the Study:

  • To analyze prescribing trends of antihypertensive drugs.
  • To examine pharmacoeconomic and pharmacoutilization aspects of these therapies.
  • To describe pharmacological differences among antihypertensive drug classes.

Main Methods:

  • Retrospective analysis of prescribing data.
  • Focus on a European healthcare setting (Italian company, ~1 million inhabitants).
  • Evaluation of drug class utilization, cost, and pharmacological profiles.

Main Results:

  • Identified distinct prescribing patterns for various antihypertensive drug classes.
  • Demonstrated considerable differences in monthly therapy costs within and between drug classes.
  • Highlighted variations in drug mechanisms, blood pressure reduction efficacy, and tolerability.

Conclusions:

  • Prescribing trends for antihypertensives are influenced by pharmacological, economic, and utilization factors.
  • Cost-effectiveness and therapeutic efficacy vary significantly across different antihypertensive drug classes.
  • Further analysis is needed to optimize antihypertensive therapy selection based on individual patient needs and economic considerations.

More Related Videos

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

3.3K
Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug05:57

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug

Published on: May 17, 2024

801

Related Concept Videos

Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
19
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
13
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
469
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
17
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
16
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
15